位置:首页 > 蛋白库 > RN165_HUMAN
RN165_HUMAN
ID   RN165_HUMAN             Reviewed;         346 AA.
AC   Q6ZSG1; B3KVD1;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   03-AUG-2022, entry version 143.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF165 {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000269|PubMed:26656854};
DE   AltName: Full=RING finger protein 165 {ECO:0000312|HGNC:HGNC:31696};
GN   Name=RNF165 {ECO:0000312|HGNC:HGNC:31696};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Cerebellum, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D., Taylor T.D.,
RA   Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Abouelleil A., Allen N.R., Anderson S., Bloom T., Bugalter B., Butler J.,
RA   Cook A., DeCaprio D., Engels R., Garber M., Gnirke A., Hafez N., Hall J.L.,
RA   Norman C.H., Itoh T., Jaffe D.B., Kuroki Y., Lehoczky J., Lui A.,
RA   Macdonald P., Mauceli E., Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C.,
RA   Noguchi H., O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [3] {ECO:0007744|PDB:5D0I, ECO:0007744|PDB:5D0K, ECO:0007744|PDB:5D0M}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 255-346 IN COMPLEX WITH ZINC;
RP   UBIQUITIN AND UBE2D2, CATALYTIC ACTIVITY, SUBUNIT, ACTIVITY REGULATION,
RP   DOMAIN, AND MUTAGENESIS OF ARG-309; MET-313 AND ARG-335.
RX   PubMed=26656854; DOI=10.1038/nsmb.3142;
RA   Wright J.D., Mace P.D., Day C.L.;
RT   "Secondary ubiquitin-RING docking enhances Arkadia and Ark2C E3 ligase
RT   activity.";
RL   Nat. Struct. Mol. Biol. 23:45-52(2016).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that acts as a regulator of motor
CC       axon elongation. Required for efficient motor axon extension in the
CC       dorsal forelimb by enhancing the transcriptional responses of the
CC       SMAD1/SMAD5/SMAD8 effectors, which are activated downstream of BMP.
CC       Acts by mediating ubiquitination and degradation of SMAD inhibitors
CC       such as SMAD6, SMAD7, SKI and SNON isoform of SKIL.
CC       {ECO:0000250|UniProtKB:E9QAU8}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000269|PubMed:26656854};
CC   -!- ACTIVITY REGULATION: Binds free ubiquitin non-covalently via its RING-
CC       type zinc finger. Ubiquitin-binding leads to enhance the E3 ubiquitin-
CC       protein ligase activity by stabilizing the ubiquitin-conjugating enzyme
CC       E2 (donor ubiquitin) in the 'closed' conformation and activating
CC       ubiquitin transfer (PubMed:26656854).
CC   -!- SUBUNIT: Monomer; binding to the ubiquitin-conjugating enzyme E2 does
CC       not trigger homodimerization (PubMed:26656854).
CC       {ECO:0000269|PubMed:26656854}.
CC   -!- INTERACTION:
CC       Q6ZSG1; P12755: SKI; NbExp=2; IntAct=EBI-2129206, EBI-347281;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:E9QAU8}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6ZSG1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6ZSG1-2; Sequence=VSP_045128;
CC   -!- DOMAIN: The RING-type zinc finger mediates the E3 ubiquitin-protein
CC       ligase activity and binds directly to free ubiquitin (PubMed:26656854).
CC       Non-covalent ubiquitin-binding stabilizes the ubiquitin-conjugating
CC       enzyme E2 (donor ubiquitin) in the 'closed' conformation and stimulates
CC       ubiquitin transfer (PubMed:26656854). {ECO:0000269|PubMed:26656854}.
CC   -!- SIMILARITY: Belongs to the Arkadia family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK127467; BAC86992.1; -; mRNA.
DR   EMBL; AK122819; BAG53743.1; -; mRNA.
DR   EMBL; AC015959; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC018931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC021763; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS32823.1; -. [Q6ZSG1-1]
DR   CCDS; CCDS58621.1; -. [Q6ZSG1-2]
DR   RefSeq; NP_001243687.1; NM_001256758.1. [Q6ZSG1-2]
DR   RefSeq; NP_689683.2; NM_152470.2. [Q6ZSG1-1]
DR   PDB; 5D0I; X-ray; 1.90 A; A/B=255-346.
DR   PDB; 5D0K; X-ray; 2.65 A; C/F/I/L=255-346.
DR   PDB; 5D0M; X-ray; 1.91 A; C=255-346.
DR   PDB; 5ULH; X-ray; 1.95 A; C=255-346.
DR   PDB; 5ULK; X-ray; 2.38 A; C=255-346.
DR   PDB; 7R70; X-ray; 2.50 A; A/B=255-346.
DR   PDB; 7R71; X-ray; 2.80 A; A=255-346.
DR   PDBsum; 5D0I; -.
DR   PDBsum; 5D0K; -.
DR   PDBsum; 5D0M; -.
DR   PDBsum; 5ULH; -.
DR   PDBsum; 5ULK; -.
DR   PDBsum; 7R70; -.
DR   PDBsum; 7R71; -.
DR   AlphaFoldDB; Q6ZSG1; -.
DR   SMR; Q6ZSG1; -.
DR   BioGRID; 138966; 11.
DR   DIP; DIP-52693N; -.
DR   IntAct; Q6ZSG1; 13.
DR   STRING; 9606.ENSP00000269439; -.
DR   BioMuta; RNF165; -.
DR   DMDM; 74762404; -.
DR   PaxDb; Q6ZSG1; -.
DR   PeptideAtlas; Q6ZSG1; -.
DR   PRIDE; Q6ZSG1; -.
DR   Antibodypedia; 9062; 134 antibodies from 17 providers.
DR   DNASU; 494470; -.
DR   Ensembl; ENST00000269439.12; ENSP00000269439.6; ENSG00000141622.14. [Q6ZSG1-1]
DR   Ensembl; ENST00000543885.2; ENSP00000444285.1; ENSG00000141622.14. [Q6ZSG1-2]
DR   GeneID; 494470; -.
DR   KEGG; hsa:494470; -.
DR   MANE-Select; ENST00000269439.12; ENSP00000269439.6; NM_152470.3; NP_689683.2.
DR   UCSC; uc002lcb.2; human. [Q6ZSG1-1]
DR   CTD; 494470; -.
DR   DisGeNET; 494470; -.
DR   GeneCards; RNF165; -.
DR   HGNC; HGNC:31696; RNF165.
DR   HPA; ENSG00000141622; Tissue enhanced (retina).
DR   neXtProt; NX_Q6ZSG1; -.
DR   OpenTargets; ENSG00000141622; -.
DR   PharmGKB; PA134972127; -.
DR   VEuPathDB; HostDB:ENSG00000141622; -.
DR   eggNOG; KOG0800; Eukaryota.
DR   GeneTree; ENSGT00940000156997; -.
DR   HOGENOM; CLU_056012_0_0_1; -.
DR   InParanoid; Q6ZSG1; -.
DR   OMA; NPHMATA; -.
DR   PhylomeDB; Q6ZSG1; -.
DR   TreeFam; TF317681; -.
DR   PathwayCommons; Q6ZSG1; -.
DR   SignaLink; Q6ZSG1; -.
DR   BioGRID-ORCS; 494470; 9 hits in 1106 CRISPR screens.
DR   ChiTaRS; RNF165; human.
DR   GenomeRNAi; 494470; -.
DR   Pharos; Q6ZSG1; Tdark.
DR   PRO; PR:Q6ZSG1; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   RNAct; Q6ZSG1; protein.
DR   Bgee; ENSG00000141622; Expressed in cortical plate and 133 other tissues.
DR   ExpressionAtlas; Q6ZSG1; baseline and differential.
DR   Genevisible; Q6ZSG1; HS.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0032991; C:protein-containing complex; IEA:Ensembl.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0035136; P:forelimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0060384; P:innervation; IEA:Ensembl.
DR   GO; GO:0008045; P:motor neuron axon guidance; IBA:GO_Central.
DR   GO; GO:0010259; P:multicellular organism aging; IEA:Ensembl.
DR   GO; GO:0061061; P:muscle structure development; IEA:Ensembl.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; IBA:GO_Central.
DR   GO; GO:0030163; P:protein catabolic process; IEA:Ensembl.
DR   GO; GO:0000209; P:protein polyubiquitination; IEA:Ensembl.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR011016; Znf_RING-CH.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00744; RINGv; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Metal-binding; Nucleus;
KW   Reference proteome; Transferase; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..346
FT                   /note="E3 ubiquitin-protein ligase RNF165"
FT                   /id="PRO_0000245587"
FT   ZN_FING         294..335
FT                   /note="RING-type; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   REGION          23..76
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          266..268
FT                   /note="Ubiquitin binding"
FT                   /evidence="ECO:0000269|PubMed:26656854,
FT                   ECO:0007744|PDB:5D0K"
FT   REGION          267..288
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          309..313
FT                   /note="Ubiquitin binding"
FT                   /evidence="ECO:0000269|PubMed:26656854,
FT                   ECO:0007744|PDB:5D0K"
FT   BINDING         294
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:26656854,
FT                   ECO:0007744|PDB:5D0I, ECO:0007744|PDB:5D0K,
FT                   ECO:0007744|PDB:5D0M"
FT   BINDING         297
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:26656854,
FT                   ECO:0007744|PDB:5D0I, ECO:0007744|PDB:5D0K,
FT                   ECO:0007744|PDB:5D0M"
FT   BINDING         317
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:26656854,
FT                   ECO:0007744|PDB:5D0I, ECO:0007744|PDB:5D0K,
FT                   ECO:0007744|PDB:5D0M"
FT   BINDING         320
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:26656854,
FT                   ECO:0007744|PDB:5D0I, ECO:0007744|PDB:5D0K,
FT                   ECO:0007744|PDB:5D0M"
FT   VAR_SEQ         1..192
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045128"
FT   MUTAGEN         309
FT                   /note="R->A: Reduced binding to free ubiquitin."
FT                   /evidence="ECO:0000269|PubMed:26656854"
FT   MUTAGEN         313
FT                   /note="M->A: Reduced binding to free ubiquitin and reduced
FT                   E3 ubiquitin-protein ligase activity."
FT                   /evidence="ECO:0000269|PubMed:26656854"
FT   MUTAGEN         335
FT                   /note="R->A: Reduced ubiquitin discharge."
FT                   /evidence="ECO:0000269|PubMed:26656854"
FT   HELIX           261..264
FT                   /evidence="ECO:0007829|PDB:5D0I"
FT   STRAND          265..269
FT                   /evidence="ECO:0007829|PDB:5D0I"
FT   TURN            295..297
FT                   /evidence="ECO:0007829|PDB:5D0I"
FT   STRAND          299..305
FT                   /evidence="ECO:0007829|PDB:5ULH"
FT   STRAND          306..309
FT                   /evidence="ECO:0007829|PDB:5D0I"
FT   STRAND          315..317
FT                   /evidence="ECO:0007829|PDB:5D0I"
FT   HELIX           318..328
FT                   /evidence="ECO:0007829|PDB:5D0I"
FT   TURN            332..334
FT                   /evidence="ECO:0007829|PDB:5D0I"
SQ   SEQUENCE   346 AA;  39526 MW;  93A5B777988C339C CRC64;
     MVLVHVGYLV LPVFGSVRNR GAPFQRSQHP HATSCRHFHL GPPQPQQLAP DFPLAHPVQS
     QPGLSAHMAP AHQHSGALHQ SLTPLPTLQF QDVTGPSFLP QALHQQYLLQ QQLLEAQHRR
     LVSHPRRSQE RVSVHPHRLH PSFDFGQLQT PQPRYLAEGT DWDLSVDAGL SPAQFQVRPI
     PQHYQHYLAT PRMHHFPRNS SSTQMVVHEI RNYPYPQLHF LALQGLNPSR HTSAVRESYE
     ELLQLEDRLG NVTRGAVQNT IERFTFPHKY KKRRPQDGKG KKDEGEESDT DEKCTICLSM
     LEDGEDVRRL PCMHLFHQLC VDQWLAMSKK CPICRVDIET QLGADS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024